Long noncoding RNAs in cardiometabolic disorders

The advancement of medical technology has led not only to an increase in life expectancy but also to a rise in aging-related diseases. Aging promotes metabolic disorders, in turn affecting cardiovascular health. Derailment of biological processes in the pancreas, liver, adipose tissue, and skeletal muscle impairs glucose and lipid metabolism, and mitochondrial function, triggering the development of diabetes and lipid-related disorders that inflict damage on cardiac and vascular tissues. Long noncoding RNAs (lncRNAs) regulate a wide range of biological process and are one of the key factors controlling metabolism and mitochondria. Here, we discuss the versatile function of lncRNAs involved in the metabolic regulation of glucose and lipid, and mitochondrial function, and how the dysregulation of lncRNAs induces the development of various metabolic disorders and their cardiovascular consequences.

Automated summary

The advancement of medical technology has led to an increase in life expectancy but also a rise in aging-related diseases. Aging affects metabolism and cardiovascular health, and long noncoding RNAs (lncRNAs) play a crucial role in regulating metabolism and mitochondrial function. Dysregulation of lncRNAs can result in various metabolic disorders and cardiovascular consequences.